ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	19/213	120/7206	1.64861228251e-09
ko04380	Osteoclast differentiation	20/213	134/7206	1.75994761506e-09
ko04060	Cytokine-cytokine receptor interaction	21/213	191/7206	1.71008816853e-07
ko04621	NOD-like receptor signaling pathway	16/213	157/7206	1.42928529713e-05
ko05160	Hepatitis C	15/213	153/7206	4.21728215207e-05
ko04657	IL-17 signaling pathway	11/213	87/7206	4.52907894143e-05
ko05323	Rheumatoid arthritis	10/213	89/7206	0.000272596284555
ko04512	ECM-receptor interaction	9/213	79/7206	0.00049705898403
ko04630	Jak-STAT signaling pathway	12/213	132/7206	0.000502103028759
ko05132	Salmonella infection	10/213	98/7206	0.000595855934253
ko05131	Shigellosis	9/213	82/7206	0.000655634938727
ko04510	Focal adhesion	17/213	240/7206	0.000710196404882
ko04210	Apoptosis	14/213	180/7206	0.000850509009326
ko05164	Influenza A	13/213	167/7206	0.00128730117456
ko05161	Hepatitis B	13/213	173/7206	0.00177335662535
ko04064	NF-kappa B signaling pathway	9/213	96/7206	0.00203145152452
ko05100	Bacterial invasion of epithelial cells	9/213	99/7206	0.00251333024256
ko04620	Toll-like receptor signaling pathway	9/213	100/7206	0.00269270866038
ko04660	T cell receptor signaling pathway	10/213	124/7206	0.00356887984909
ko05145	Toxoplasmosis	10/213	126/7206	0.00400403960223
ko04917	Prolactin signaling pathway	8/213	87/7206	0.00402506938037
ko05133	Pertussis	8/213	87/7206	0.00402506938037
ko04672	Intestinal immune network for IgA production	5/213	37/7206	0.00434102735121
ko00643	Styrene degradation	2/213	4/7206	0.00501684988369
ko05120	Epithelial cell signaling in Helicobacter pylori infection	8/213	92/7206	0.00565621575754
ko04933	AGE-RAGE signaling pathway in diabetic complications	10/213	135/7206	0.00650766014867
ko04610	Complement and coagulation cascades	7/213	79/7206	0.00854498932464
ko05144	Malaria	5/213	45/7206	0.0100586179464
ko05168	Herpes simplex infection	12/213	182/7206	0.011495446125
ko05219	Bladder cancer	5/213	48/7206	0.0131301255677
ko04151	PI3K-Akt signaling pathway	20/213	390/7206	0.0135762732005
ko05167	Kaposi's sarcoma-associated herpesvirus infection	12/213	191/7206	0.0138659080035
ko04810	Regulation of actin cytoskeleton	15/213	264/7206	0.0142570792495
ko05142	Chagas disease (American trypanosomiasis)	9/213	130/7206	0.0146098578721
ko04662	B cell receptor signaling pathway	7/213	88/7206	0.0149927038386
ko04915	Estrogen signaling pathway	9/213	131/7206	0.0152983479831
ko00350	Tyrosine metabolism	4/213	33/7206	0.0155160068576
ko04068	FoxO signaling pathway	11/213	167/7206	0.0166857657371
ko04931	Insulin resistance	9/213	137/7206	0.0199411309228
ko05134	Legionellosis	6/213	74/7206	0.0217186221458
ko04115	p53 signaling pathway	6/213	74/7206	0.0217186221458
ko04932	Non-alcoholic fatty liver disease (NAFLD)	11/213	182/7206	0.0227687671823
ko04974	Protein digestion and absorption	7/213	96/7206	0.0231339502825
ko04658	Th1 and Th2 cell differentiation	7/213	96/7206	0.0231339502825
ko05321	Inflammatory bowel disease (IBD)	5/213	56/7206	0.0242542493346
ko05162	Measles	8/213	120/7206	0.025417851499
ko00401	Novobiocin biosynthesis	1/213	1/7206	0.0295587010825
ko01522	Endocrine resistance	8/213	124/7206	0.030163841826
ko05166	HTLV-I infection	15/213	292/7206	0.0328207812068
ko05418	Fluid shear stress and atherosclerosis	10/213	173/7206	0.037286847696
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/213	11/7206	0.0401258857108
ko04010	MAPK signaling pathway	16/213	321/7206	0.0404111907388
ko05210	Colorectal cancer	6/213	86/7206	0.0413324362148
ko04670	Leukocyte transendothelial migration	9/213	151/7206	0.0448600304383
ko04920	Adipocytokine signaling pathway	6/213	89/7206	0.0475567630682
ko04215	Apoptosis - multiple species	4/213	47/7206	0.0492426342729